Rule 8.3 - INVERNESS MEDICAL INNOVATIONS INC

The Rule 8.3 report published earlier today showed incorrect data regarding open positions in the Supplemental Form. This has been corrected. FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the City Code on Takeovers and Mergers) 1. KEY INFORMATION Name of person dealing BARCLAYS PLC (Note 1) Company dealt in INVERNESS MEDICAL INNOVATIONS INC Class of relevant security COM STK USD0.001 to which the dealings being disclosed relate (Note 2) Date of dealing 26 June 2009 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) Long Short Number (%) Number (%) (1) Relevant 2,138,307 2.72% 115,755 0.15% securities (2) Derivatives 0 0.00% (other than options) (3) Options and 120,600 0.15% 53,500 0.07% agreements to purchase/sell Total 2,258,907 2.87% 169,255 0.21% (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) Class of Long Short relevant security: Number (%) Number (%) (1) Relevant securities (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total (c) Rights to subscribe (Note 3) Class of relevant security: Details 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of Securities Price per unit (GBP) Purchase 20 35.3371 Purchase 671 35.3500 USD Purchase 679 35.3323 USD Purchase 785 35.3323 USD Purchase 854 35.3238 USD Purchase 999 35.3500 USD Purchase 1,036 35.3500 USD Purchase 2,794 35.3238 USD Purchase 3,411 35.3238 USD Purchase 4,976 35.3238 USD Purchase 100 35.22 Purchase 37 35.35 Purchase 463 35.3323 USD Purchase 35 35.3465 Purchase 565 35.3288 Purchase 820 35.3355 Purchase 143 35.35 Purchase 1,500 35.3296 Purchase 78 35.36153846 Purchase 40 35.35 Purchase 20 35.3296 Purchase 100 35.27 Purchase 7,414 35.3238 USD Purchase 92 35.3500 USD Purchase 2 35.3500 USD Purchase 5 35.3500 USD Purchase 17 35.3500 USD Purchase 34 35.3500 USD Purchase 36 35.3238 USD Purchase 38 35.3500 USD Purchase 48 35.3500 USD Purchase 48 35.3500 USD Purchase 62 35.3500 USD Purchase 614 35.3238 USD Purchase 83 35.3500 USD Purchase 601 35.3238 USD Purchase 106 35.3500 USD Purchase 115 35.3500 USD Purchase 123 35.3323 USD Purchase 169 35.3500 USD Purchase 284 35.3238 USD Purchase 355 35.3323 USD Purchase 357 35.3323 USD Purchase 376 35.3500 USD Purchase 459 35.3500 USD Purchase 255 35.33939216 Purchase 79 35.3500 USD Purchase 500 35.462 Purchase 111 35.26527027 Purchase 100 35.24 Purchase 200 35.345 Purchase 100 35.34 Purchase 100 35.35 Purchase 100 35.42 Purchase 500 35.2748 Purchase 1,500 35.3296 Purchase 200 35.212 Purchase 200 35.435 Purchase 400 35.49 Purchase 300 35.212 Purchase 300 35.19 Purchase 2,100 35.26142857 Purchase 300 35.28 Purchase 400 35.49 Purchase 600 35.3107 Purchase 100 35.34 Purchase 2,400 35.26375 Purchase 1,420 35.35 Purchase 100 35.28 Sale 400 35.37 Sale 8,100 35.3191358 Sale 350 35.3500 USD Sale 800 35.25125 Sale 900 35.38333333 Sale 140 35.3500 USD Sale 300 35.28 Sale 1,346 35.33763744 Sale 115 35.3500 USD Sale 300 35.49 Sale 600 35.31066667 Sale 92 35.3500 USD Sale 7,884 35.27375698 Sale 79 35.3500 USD Sale 2,100 35.26142857 Sale 1,400 35.29214286 Sale 100 35.42 Sale 565 35.3288 Sale 41 35.3500 USD Sale 100 35.34 Sale 38 35.3500 USD Sale 20 35.3371 Sale 700 35.3614 Sale 700 35.39057143 Sale 35 35.3465 Sale 100 35.27 Sale 83 35.3500 USD Sale 1,144 35.3500 USD Sale 20 35.3296 Sale 143 35.35 Sale 1,500 35.3296 Sale 444 35.35 Sale 336 35.44154762 Sale 400 35.305 Sale 300 35.42 Sale 620 35.33006694 Sale 37 35.35 Sale 6,579 35.3500 USD Sale 255 35.33939216 Sale 671 35.35 Sale 3,200 35.37440313 Sale 1,157 35.3500 USD Sale 100 35.49 Sale 1,036 35.3500 USD Sale 100 35.22 Sale 2 35.3500 USD Sale 820 35.3355 Sale 849 35.35 Sale 4,893 35.35 Sale 147 35.35 Sale 111 35.26527027 Sale 2,400 35.26375 Sale 538 35.3500 USD Sale 870 35.34804598 Sale 820 35.3355 Sale 1,075 35.35 (b) Derivatives transactions (other than options) Product name, Long/Short Number of Price per (e.g. CFD) (Note 6) Securities unit (GBP) (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product name, Writing, Number of Exercise Type, e.g. Expiry Option money e.g. call selling, securities to price American, date paid/received option purchasing, which the option European etc. per unit (GBP) varying etc. relates (GBP) (ii) Exercising Product name, e.g. Number of Exercise price per call option securities unit (Note 5) (d) Other dealings (including new securities) (Note 4) Nature of transaction Details Price per unit (Note 8) (if applicable) (Note 5) 4. OTHER INFORMATION None Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. Is a Supplemental Form 8 attached? (Note 9) YES Date of disclosure 29 June 2009 Contact name Geoff Smith Telephone number 020 7116 2913 If a connected EFM, name of offeree/offeror with which connected If a connected EFM, state nature of connection (Note 10) Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk SUPPLEMENTAL FORM 8 DETAILS OF OPEN POSITIONS (This form should be attached to Form 8.1, Form 8.1(b)(ii) or Form 8.3, as appropriate) OPEN POSITIONS (Note 1) Product name, Written or Number of securities Exercise price Type, e.g. Expiry date e.g. call option purchased to which the option (Note 2) American, or derivative relates European etc. Option Purchased -100 17.5000 AMER 22/08/2009 Option Purchased -2,400 25.0000 AMER 16/01/2010 Option Purchased 500 35.0000 AMER 18/07/2009 Option Purchased 400 50.0000 AMER 21/11/2009 Option Purchased 200 15.0000 AMER 22/01/2011 Option Purchased 100 35.0000 AMER 22/08/2009 Option Purchased 100 25.0000 AMER 20/02/2010 Option Purchased 100 22.5000 AMER 22/01/2011 Option Purchased 100 17.5000 AMER 22/01/2011 Option Purchased 100 15.0000 AMER 16/01/2010 Option Purchased 700 35.0000 AMER 16/01/2010 Option Purchased -100 25.0000 AMER 21/11/2009 Option Purchased 900 22.5000 AMER 22/08/2009 Option Purchased -100 17.5000 AMER 16/01/2010 Option Purchased -500 20.0000 AMER 22/08/2009 Option Purchased -500 20.0000 AMER 22/08/2009 Option Purchased -600 30.0000 AMER 21/11/2009 Option Purchased -700 40.0000 AMER 16/01/2010 Option Purchased -900 30.0000 AMER 18/07/2009 Option Purchased -1,200 30.0000 AMER 22/01/2011 Option Purchased -2,000 40.0000 AMER 18/07/2009 Option Purchased -2,000 22.5000 AMER 22/08/2009 Option Purchased 100 12.5000 AMER 22/01/2011 Option Purchased 3,100 35.0000 AMER 21/11/2009 Option Purchased -4,600 25.0000 AMER 16/01/2010 Option Purchased -11,100 30.0000 AMER 18/07/2009 Option Purchased -23,900 25.0000 AMER 22/08/2009 Option Purchased 40,000 35.0000 AMER 22/08/2009 Option Purchased 22,300 25.0000 AMER 22/08/2009 Option Purchased 8,000 35.0000 AMER 22/08/2009 Option Purchased 6,900 30.0000 AMER 16/01/2010 Option Purchased 6,400 30.0000 AMER 16/01/2010 Option Purchased 5,800 40.0000 AMER 22/08/2009 Option Purchased 700 30.0000 AMER 22/08/2009 Option Purchased 4,400 20.0000 AMER 16/01/2010 Option Purchased -2,800 35.0000 AMER 18/07/2009 Option Purchased 2,700 50.0000 AMER 16/01/2010 Option Purchased 2,500 45.0000 AMER 21/11/2009 Option Purchased 2,300 45.0000 AMER 16/01/2010 Option Purchased 1,800 40.0000 AMER 22/01/2011 Option Purchased 1,600 30.0000 AMER 22/08/2009 Option Purchased 1,400 40.0000 AMER 21/11/2009 Option Purchased 1,100 30.0000 AMER 21/11/2009 Option Purchased 1,000 55.0000 AMER 22/01/2011 Option Purchased 900 25.0000 AMER 22/01/2011 Option Purchased 4,400 35.0000 AMER 16/01/2010 Notes 1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell should also be given on this form. 2. For all prices and other monetary amounts, the currency must be stated. For details of the Code's dealing disclosure requirements, see Rule 8 and its Notes which can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

Companies

Barclays (BARC)
UK 100

Latest directors dealings